New Regulatory Information Management Applications Added to ViewPoint Quantum Platform Advance Octagon's Regulatory Cloud Strategy
Octagon Research Solutions announced its two additions to its Quantum Regulatory Information Management platform. Content Manager and Document Publisher join Submission Manager as the next applications built on Octagon’s Quantum Platform. This new platform provides industry with a single, consolidated system to provide highly scalable, and top tier capabilities to life science companies.
The Quantum Content Manager Business Application provides process controls across the document lifecycle and offers a secure and collaborative environment for content creation, review, and finalization.
The Quantum Document Publisher Business Application provides PDF manipulation functionality supporting:
- Document navigation and the creation and modification of bookmarks and hyperlinks
- Document maintenance activities such as scaling, rotating and cropping
- Document enhancements such as the application of headers, footers and pagination
Combined with Octagon’s existing Submission Manager application, organizations have the capability to develop and publish content from a single, flexible, and pre-configured system.
“We are very pleased to be able to preview these two business modules that leverage the strong process management capabilities of the Quantum platform,” said James C. Walker, chairman and CEO, Octagon Research Solutions, Inc. “Content Manager and Document Publisher address the challenges of managing the document lifecycle while improving the quality, consistency and value of the final content deliverables.”
The two new business applications are integral components of Octagon’s cloud strategy. Though the Quantum platform and business modules are available in a traditional on-premise installation, the release of these new modules enables Octagon to provide an end-to-end, cloud-based solution that joins document and submissions lifecycles in a hosted environment.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
